Zealand Pharma
The Senior Drug Substance Scientist leads late-stage drug substance development and CDMO collaboration for synthetic peptides, acting as a strategic anchor within the CMC team. This role involves driving technical transfer, upscale activities, and regulatory submissions while managing external manufacturing partnerships. The position requires a collaborative expert to shape drug substance strategy and ensure progress toward regulatory approval.
Headquarters
Søborg, Hovedstaden, Denmark
Company Size
201-500 employees
Founded
1998
N/A
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Zealand Pharma.
Zealand Pharma didn’t post a salary, so this is our estimate from similar listings.
24% above the average for this role
Senior Research Scientist, Synthetic Molecule API Development
Elanco
Director, Drug Substance Commercial Manufacturing
kaileratherapeutics
Research Fellow in Organic Chemistry
Nanyang Technological University
Postdoctoral Researcher
NationalunP2
Senior Principal Scientist, Peptide Chemistry / API Development
Neurocrine Biosciences
Senior Director, Drug Substance Development
altimmune